LDB Banner LDB Home    NHLBI Research Home
Skip left side navigation and go to content <% urlStr = Request.ServerVariables("PATH_INFO") %> <% getLeftNav(getLabStr(urlStr)) %> Skip left side navigation and go to content
Skip left side navigation and go to content


Developmental Glycobiology Section


Kenneth Kramer, PhD, Principal Investigator

 

COOH Image

On the surface of virtually every cell are sugar-protein macromolecules known as heparan sulfate proteoglycans, and embryos that lack proteoglycans die early in development. The laboratory’s main research objective is to understand how proteoglycans regulate early zebrafish development. We use zebrafish as a model system because several genetic tools enable us to readily manipulate HSPGs during development, an approach that is critical to understanding how proteoglycans function. The cardiovascular system is particularly sensitive to our manipulations, and we are discovering multiple roles for proteoglycans during cardiovascular development. We are also developing new tools to decipher the spatial and temporal “heparan code”, an array of tissue-specific heparan sulfate modifications that have been proposed to mediate development. Because heparan sulfate and many steps in zebrafish embryogenesis are similar to those in humans, we expect the tools, mechanisms and modifiers that we identify will be applicable to better understanding a wide range of cell-cell signaling events in development and disease.


Main Projects:

 


jump over rollover images to navigation links

NHLBI HOME · SEARCH NHLBI · ACCESSIBILITY INFORMATION · NHLBI SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT NHLBI

Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute